The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | Common | 00434H108 | 151,916 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | Sponsored ADR | 00653A107 | 87,780 | 11,000,000 | SH | SOLE | 11,000,000 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | Common | 00773U108 | 82,400 | 8,000,000 | SH | SOLE | 8,000,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259202 | 2,022 | 415,999 | SH | SOLE | 415,999 | 0 | 0 | ||
| ALTIMMUNE INC | Common | 02155H200 | 26,400 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| AMARIN CORP PLC | Sponsored ADR | 023111206 | 25,260 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 153,202 | 10,850,000 | SH | SOLE | 10,850,000 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | Common | 040047607 | 231,849 | 3,100,000 | SH | SOLE | 3,100,000 | 0 | 0 | ||
| ARGENX SE | Sponsored ADR | 04016X101 | 236,924 | 902,500 | SH | SOLE | 902,500 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 277,776 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
| ATHENEX INC | Common | 04685N103 | 39,507 | 3,265,000 | SH | SOLE | 3,265,000 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | Sponsored ADR | 05337M104 | 21,168 | 4,200,000 | SH | SOLE | 4,200,000 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | Common | 05370A108 | 15,342 | 545,000 | SH | SOLE | 545,000 | 0 | 0 | ||
| BCTG ACQUISITION CORP | Common | 05492W103 | 8,672 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 133,140 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| BLACK DIAMOND THERAPEUTICS INC | Common | 09203E105 | 18,214 | 602,500 | SH | SOLE | 602,500 | 0 | 0 | ||
| CONSTELLATION PHARMACEUTICALS INC | Common | 210373106 | 86,612 | 4,275,000 | SH | SOLE | 4,275,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | Common | 22978P106 | 28,144 | 1,870,000 | SH | SOLE | 1,870,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | 74,572 | 10,300,000 | SH | SOLE | 10,300,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | 93,366 | 1,820,000 | SH | SOLE | 1,820,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 10,120 | 1,670,000 | SH | SOLE | 1,670,000 | 0 | 0 | ||
| GENOCEA BIOSCIENCES INC | Common | 372427401 | 11,643 | 5,084,184 | SH | SOLE | 5,084,184 | 0 | 0 | ||
| HORIZON THERAPEUTICS PLC | Common | G46188101 | 594,252 | 7,650,000 | SH | SOLE | 7,650,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 2,232,038 | 26,250,000 | SH | SOLE | 26,250,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 313,926 | 9,536,039 | SH | SOLE | 9,536,039 | 0 | 0 | ||
| ITEOS THERAPEUTICS INC | Common | 46565G104 | 11,348 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
| IVERIC BIO INC | Common | 46583P102 | 40,890 | 7,250,000 | SH | SOLE | 7,250,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | Common | 48576U106 | 87,600 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | Common | 50127T109 | 74,608 | 2,435,000 | SH | SOLE | 2,435,000 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | Common | 501575104 | 1,596 | 49,400 | SH | SOLE | 49,400 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 105,670 | 890,000 | SH | SOLE | 890,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | Common | 56854Q101 | 38,550 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | Common | 59045L106 | 126,616 | 6,800,000 | SH | SOLE | 6,800,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 721,155 | 4,343,000 | SH | SOLE | 4,343,000 | 0 | 0 | ||
| MYOKARDIA INC | Common | 62857M105 | 256,982 | 1,885,000 | SH | SOLE | 1,885,000 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | Common | 69353Y103 | 57,578 | 1,850,000 | SH | SOLE | 1,850,000 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | Common | 75382E109 | 18,515 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | Common | 75943R102 | 21,295 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | Common | 75955J402 | 56,430 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| RETROPHIN INC | Common | 761299106 | 24,460 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 235,220 | 1,675,000 | SH | SOLE | 1,675,000 | 0 | 0 | ||
| THERAPEUTICS ACQUISITION CORP | Common | 88339T103 | 14,380 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 78,155 | 5,500,000 | SH | SOLE | 5,500,000 | 0 | 0 | ||
| UNIQURE NV | Common | N90064101 | 64,453 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 30,996 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
| ZOGENIX INC | Common | 98978L204 | 15,689 | 875,000 | SH | SOLE | 875,000 | 0 | 0 | ||